Specifically, CD19+ cells (expressing the B-cell antigen CD19) are the dominant and most proliferative cells in BCP-ALL samples, constituting more than 90 % of the entire population [23]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.